4D Molecular Therapeutics Inc (FDMT)
8.175
+0.08
(+0.99%)
USD |
NASDAQ |
Nov 04, 16:00
8.20
+0.02
(+0.31%)
After-Hours: 07:28
4D Molecular Therapeutics Market Cap: 424.85M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 424.85M |
| November 01, 2024 | 420.69M |
| October 31, 2024 | 416.28M |
| October 30, 2024 | 429.79M |
| October 29, 2024 | 426.15M |
| October 28, 2024 | 445.38M |
| October 25, 2024 | 423.55M |
| October 24, 2024 | 426.67M |
| October 23, 2024 | 442.26M |
| October 22, 2024 | 429.27M |
| October 21, 2024 | 445.90M |
| October 18, 2024 | 443.30M |
| October 17, 2024 | 439.14M |
| October 16, 2024 | 450.06M |
| October 15, 2024 | 462.01M |
| October 14, 2024 | 469.29M |
| October 11, 2024 | 476.56M |
| October 10, 2024 | 453.69M |
| October 09, 2024 | 467.73M |
| October 08, 2024 | 487.47M |
| October 07, 2024 | 481.24M |
| October 04, 2024 | 518.14M |
| October 03, 2024 | 537.37M |
| October 02, 2024 | 533.73M |
| October 01, 2024 | 541.00M |
| Date | Value |
|---|---|
| September 30, 2024 | 561.79M |
| September 27, 2024 | 562.83M |
| September 26, 2024 | 569.59M |
| September 25, 2024 | 586.22M |
| September 24, 2024 | 597.13M |
| September 23, 2024 | 603.37M |
| September 20, 2024 | 618.44M |
| September 19, 2024 | 701.59M |
| September 18, 2024 | 874.13M |
| September 17, 2024 | 839.83M |
| September 16, 2024 | 856.46M |
| September 13, 2024 | 844.51M |
| September 12, 2024 | 826.84M |
| September 11, 2024 | 816.96M |
| September 10, 2024 | 806.05M |
| September 09, 2024 | 792.54M |
| September 06, 2024 | 783.18M |
| September 05, 2024 | 806.05M |
| September 04, 2024 | 811.77M |
| September 03, 2024 | 766.03M |
| August 30, 2024 | 780.06M |
| August 29, 2024 | 792.54M |
| August 28, 2024 | 795.13M |
| August 27, 2024 | 807.09M |
| August 26, 2024 | 823.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
183.46M
Minimum
Jun 16 2022
1.786B
Maximum
Mar 27 2024
736.23M
Average
707.72M
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 91.08B |
| Ocular Therapeutix Inc | 1.601B |
| NovaBay Pharmaceuticals Inc | 3.694M |
| Palatin Technologies Inc | 23.26M |
| iBio Inc | 23.06M |
Market Cap Related Metrics
| PS Ratio | 19.17 |
| Price to Book Value | 0.7221 |
| Price | 8.175 |
| Earnings Yield | -28.13% |